Abstract: Background: Although triple therapy regimens suggested in the Current European guidelines give fairly good results, several studies have reported an unsatisfactory Helicobacter pylori eradication rate (< 80%). Aim: To evaluate the efficacy of a new short-term treatment sequence on H. pylori eradication. Methods: A total of 52 patients with H. pylori infection and either non-ulcer dyspepsia (34 patients) or peptic ulcer (18 patients) were enrolled to receive a 10-day therapy: omeprazole 20 mg b.d. plus amoxycillin 1 g b.d. for the first 5 days, followed by omeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. for the remaining 5 days. H. pylori infection at entry was assessed by rapid urease test and histology on biopsies from the antrum and the corpus. Bacterial eradication was assessed by endoscopy (peptic ulcer patients) or C-13 urea breath test (non-ulcer dyspepsia patients) 4-6 weeks after therapy had ended. Results: All patients completed the study. H. pylori eradication was achieved in all but one patient, with an eradication rate of 98% (95% CI: 94.3-100) with intention-to-treat analysis. Patient compliance was good (consumption of prescribed drugs > 95%) for all but one patient, who took the triple therapy regimen for 4 days instead of 5 days. No major side-effects were reported but three (6%) patients complained of mild side-effects. Conclusions: The use of this 'five plus five' therapy schedule as an initial treatment for H. pylori deserves further investigation.

A new highly effective short-term therapy schedule for Helicobacter pylori eradication / Zullo, A; Rinaldi, Vittorio Mario; Winn, S; Meddi, P; Lionetti, R; Hassan, C; Rpani, C; Tomaselli, G; Attili, Adolfo Francesco. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - STAMPA. - 14:6(2000), pp. 715-718. [10.1046/j.1365-2036.2000.00766.x]

A new highly effective short-term therapy schedule for Helicobacter pylori eradication.

RINALDI, Vittorio Mario;ATTILI, Adolfo Francesco
2000

Abstract

Abstract: Background: Although triple therapy regimens suggested in the Current European guidelines give fairly good results, several studies have reported an unsatisfactory Helicobacter pylori eradication rate (< 80%). Aim: To evaluate the efficacy of a new short-term treatment sequence on H. pylori eradication. Methods: A total of 52 patients with H. pylori infection and either non-ulcer dyspepsia (34 patients) or peptic ulcer (18 patients) were enrolled to receive a 10-day therapy: omeprazole 20 mg b.d. plus amoxycillin 1 g b.d. for the first 5 days, followed by omeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. for the remaining 5 days. H. pylori infection at entry was assessed by rapid urease test and histology on biopsies from the antrum and the corpus. Bacterial eradication was assessed by endoscopy (peptic ulcer patients) or C-13 urea breath test (non-ulcer dyspepsia patients) 4-6 weeks after therapy had ended. Results: All patients completed the study. H. pylori eradication was achieved in all but one patient, with an eradication rate of 98% (95% CI: 94.3-100) with intention-to-treat analysis. Patient compliance was good (consumption of prescribed drugs > 95%) for all but one patient, who took the triple therapy regimen for 4 days instead of 5 days. No major side-effects were reported but three (6%) patients complained of mild side-effects. Conclusions: The use of this 'five plus five' therapy schedule as an initial treatment for H. pylori deserves further investigation.
2000
OMEPRAZOLE PLUS CLARITHROMYCIN, TRIPLE-THERAPY, DUODENAL-ULCER, INFECTION, AMOXICILLIN, LANSOPRAZOLE, PATHOGENESIS, COMBINATION, TINIDAZOLE, REGIMENS
01 Pubblicazione su rivista::01a Articolo in rivista
A new highly effective short-term therapy schedule for Helicobacter pylori eradication / Zullo, A; Rinaldi, Vittorio Mario; Winn, S; Meddi, P; Lionetti, R; Hassan, C; Rpani, C; Tomaselli, G; Attili, Adolfo Francesco. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - STAMPA. - 14:6(2000), pp. 715-718. [10.1046/j.1365-2036.2000.00766.x]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/27897
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 42
  • Scopus 154
  • ???jsp.display-item.citation.isi??? 130
social impact